# Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

> **NCT02587351** · PHASE3 · TERMINATED · sponsor: **University of Minnesota** · enrollment: 532 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Metoprolol succinate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02587351
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 532 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2021-01-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587351, "Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02587351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*